好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

What Should Be the [Delta]NIHSS Threshold for the Definition of Neurological Deterioration in Acute Ischemic Stroke?
Cerebrovascular Disease and Interventional Neurology
(-)
001
Authors/Disclosures
James E. Siegler III, MD (University of Chicago) Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siegler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Siegler has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Society of Vascular and Interventional Neurology. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. Dr. Siegler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various medicolegal cases. The institution of Dr. Siegler has received research support from Viz.ai.
Michael Gillette No disclosure on file
Karen C. Albright, DO, DO, PhD, MS, MPH (FDA) Dr. Albright has nothing to disclose.
Amelia K. Boehme, PhD (Columbia University) Dr. Boehme has nothing to disclose.
Sheryl Martin-Schild, MD, PhD, FAAN (Dr. Brain, Inc.) No disclosure on file
Frederic Sedel No disclosure on file